tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market
ABOS
Acumen Pharmaceuticals
RESEARCH TOOLSreports

Acumen Pharmaceuticals (ABOS) Financial Statements

Compare
723 Followers

Acumen Pharmaceuticals Financial Overview

Acumen Pharmaceuticals's market cap is currently $154.46M. The company's EPS TTM is $-0.4; its P/E ratio is -1.05; Acumen Pharmaceuticals is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -169.00K$ -12.30M
Operating Income$ -123.83M$ -114.02M$ -61.14M$ -45.24M$ -19.58M
EBITDA$ -123.83M$ -98.08M$ -51.61M$ -42.69M$ -19.58M
Net Income$ -121.33M$ -102.33M$ -52.37M$ -42.86M$ -100.61M
Balance Sheet
Cash & Short-Term Investments$ 116.86M$ 171.56M$ 243.52M$ 177.60M$ 194.24M
Total Assets$ 122.83M$ 238.99M$ 310.13M$ 196.59M$ 230.33M
Total Debt$ 8.77M$ 29.70M$ 28.49M$ 105.00K$ 0.00
Net Debt$ -45.22M$ -5.92M$ -38.40M$ -130.00M$ -122.16M
Total Liabilities$ 52.40M$ 57.18M$ 43.15M$ 7.81M$ 5.15M
Stockholders' Equity$ 70.43M$ 181.82M$ 266.97M$ 188.78M$ 225.18M
Cash Flow
Free Cash Flow$ -115.63M$ -86.23M$ -43.09M$ -35.31M$ -18.00M
Operating Cash Flow$ -115.54M$ -86.22M$ -43.06M$ -35.15M$ -17.96M
Investing Cash Flow$ 133.93M$ 48.03M$ -171.67M$ 39.19M$ -104.12M
Financing Cash Flow$ -34.00K$ 6.93M$ 151.75M$ 3.91M$ 200.47M
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

Income Statement >

Acumen Pharmaceuticals Debt to Assets

Balance Sheet >

Acumen Pharmaceuticals Cash Flow

Cash Flow >

Acumen Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >